hotspot -WSS

hotspot

author：explore 2025-09-28 21:56:48 - browse：3891

Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid to be the first to develop a safer, simpler, and more scalable cure for sickle cell disease.

The French drugmaker will pay Scribe $40 million upfront and promise another $1.2 billion in potential milestones to license a DNA-cutting enzyme called CasX for use in a potential single-infusion treatment for the serious blood disorder — what’s known as in vivo therapy.CasX was discovered in CRISPR pioneer Jennifer Doudna’s lab, which subsequently spun out Scribe.

Scribe was planning to announce the news Tuesday, but it was published early Monday by GEN.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Cancer cells are shown to suck energy source from immune cells

hotspot

WSS

Humana CEO Bruce Broussard to step down in 2024

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Akero's treatment for NASH falls short in cirrhosis study

Liver decline slowed by off

Digital health: a case of mistaken identity

FDA poised to publish guidelines for clinical trial diversity

focus

hotspot

hotspot

In Memoriam: Notable people who died in 2023

For longer

Medical records are filled with copy

H5N1 virus can be tracked in retail milk, scientists say

What does generative AI mean for health care? We asked experts

STAT Readout: Today's biotech news includes Sana and Amylyx

State Dept. review finds Biden bears some blame for Afghanistan failures

What the Wegovy shortage looks like for doctors — and for patients

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Liver decline slowed by off

hotspot

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Cue Health, Covid

Cue Health, Covid

How doctors and nurses shape Google's AI

Eight reasons why you should get an updated Covid vaccine

Eight reasons why you should get an updated Covid vaccine

hotspot

knowledge

hotspot

leisure time